CalciMedica company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

calcimedica.com

Total Raised

$104.49M

Investors Count

6

Deal Terms

3

CalciMedica Funding, CalciMedica Valuation & CalciMedica Revenue

13 Fundings

CalciMedica's latest funding round was a Series D for $21M on March 12, 2021.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

3/12/2021

Series D

$21M

0

FY undefined

4

5/22/2020

Unattributed VC

$15M

0

FY undefined

4

4/24/2014

Series C - V

$2.5M

0

FY undefined

1

7/15/2013

Debt - IV

$99M

0

FY undefined

10

11/5/2012

Debt - III

$99M

0

FY undefined

0

Date

3/12/2021

5/22/2020

4/24/2014

7/15/2013

11/5/2012

Round

Series D

Unattributed VC

Series C - V

Debt - IV

Debt - III

Amount

$21M

$15M

$2.5M

$99M

$99M

Investors

Valuation

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

4

4

1

10

0

CalciMedica Deal Terms

3 Deal Terms

CalciMedica's deal structure is available for 3 funding rounds, including their Series C - V from April 24, 2014.

Round

Series C - V

Series B

Series A

Funding Date

$99M

$99M

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

$99M

$99M

Shares Authorized

Issuance Price

$99M

$99M

Dividend Rate

$99M

$99M

Liquidation Preferences

$99M

$99M

Liquidation Price

Participation

$99M

$99M

Conversion Price

Anti Dilution

$99M

$99M

General Voting

$99M

$99M

$99M

Board Voting

$99M

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series C - V

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series B

$99M

$99M

$99M

$99M

Series A

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

CalciMedica Investors

6 Investors

CalciMedica has 6 investors. Sanderling Ventures invested in CalciMedica's Series D funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

1/15/2008

3/12/2021

12
Series C, Series C - II (2009), Series C - III (2009), Series B (2008), Series C - IV (2011), Debt (2011), Debt - II (2012), Debt - III (2012), Debt - IV (2013), Series C - V (2014), Unattributed VC (2020), Series D (2021)

Venture Capital

California

00/00/0000

00/00/0000

Valence Life Sciences

Subscribe to see more

Venture Capital

New York

00/00/0000

00/00/0000

Quark Venture

Subscribe to see more

Venture Capital

Canada

00/00/0000

00/00/0000

Mesa Verde Venture Partners

Subscribe to see more

Venture Capital

California

00/00/0000

00/00/0000

SR One

Subscribe to see more

Subscribe to see more

Corporate Venture

Pennsylvania

First funding

1/15/2008

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

3/12/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Valence Life Sciences

Quark Venture

Mesa Verde Venture Partners

SR One

Rounds

12
Series C, Series C - II (2009), Series C - III (2009), Series B (2008), Series C - IV (2011), Debt (2011), Debt - II (2012), Debt - III (2012), Debt - IV (2013), Series C - V (2014), Unattributed VC (2020), Series D (2021)

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Type

Venture Capital

Venture Capital

Venture Capital

Venture Capital

Corporate Venture

Location

California

New York

Canada

California

Pennsylvania

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.